Moreover, MMP2 expression was not associated with ccRCC prognosis (Supplement 1B), indicating that G6PD mediated ccRCC progression may be depended on other more important underlying mechanisms. This evidence concerns the gene G6PD and nonpapillary renal cell carcinoma.